title: A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
authors.forename: Lydia
authors.initials: L
authors.lastname: Deschamps
authors.forename: Aissatou
authors.initials: A
authors.lastname: Signate
authors.forename: Christine
authors.initials: C
authors.lastname: Delaunay
authors.forename: Ivana
authors.initials: I
authors.lastname: Morales
authors.forename: Andre
authors.initials: A
authors.lastname: Warter
authors.forename: Didier
authors.initials: D
authors.lastname: Smadja
authors.forename: Christian
authors.initials: C
authors.lastname: Derancourt
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D008297:Male; D009383:Neoplasms, Vascular Tissue / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone